Edarbi is intended for oral use, tablets can be taken regardless of meals.
The recommended starting dose is 40 mg 1 time a day.
For patients in whom the dose does not adequately control blood pressure, the dose may be increased to a maximum recommended dose of 80 mg 1 time a day.
Sustained antihypertensive effect is achieved within 2 weeks of treatment. The maximum effect is achieved after 4 weeks treatment drug.
| Manufacturer | Takeda |
|---|---|
| Brand Name | EDARBI |
| Dosage | Used as directed |
| Dosage Form | TABLETS |
| Size | 28 |
| Active Ingredients | azilsartan medoxomil |
| Side Effects | N/A |
| Contraindications | Hypersensitivity to the active substance or any other drug. Second or third trimester of pregnancy. Do not use together with aliskirenom patients with diabetes. |
Write Your Own Review